Gene · 5464
Papers3,642
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,642
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The TFIIS N-terminal domain (TND): a transcription assembly module at the interface of order and disorder. | Biochem Soc Trans | 2023 | 36651856 | PubTator, text mining | PubMed |
| Extru-seq: a method for predicting genome-wide Cas9 off-target sites with advantages of both cell-based and in vitro approaches. | Genome Biol | 2023 | 36627653 | PubTator, text mining | PubMed |
| The Bacteriophage-Phage-Inducible Chromosomal Island Arms Race Designs an Interkingdom Inhibitor of dUTPases. | Microbiol Spectr | 2023 | 36622213 | PubTator, text mining | PubMed |
| Identification of biomarkers and outcomes of endocrine disruption in human ovarian cortex using In Vitro Models. | Toxicology | 2023 | 36621641 | PubTator, text mining | PubMed |
| Signaling pathways and regulation of gene expression in hematopoietic cells. | Adv Biol Regul | 2023 | 36621151 | PubTator, text mining | PubMed |
| RNA:RNA interaction in ternary complexes resolved by chemical probing. | RNA | 2023 | 36617673 | PubTator, text mining | PubMed |
| Silencing DTX3L Inhibits the Progression of Cervical Carcinoma by Regulating PI3K/AKT/mTOR Signaling Pathway. | Int J Mol Sci | 2023 | 36614304 | PubTator, text mining | PubMed |
| Targeted systematic evolution of an RNA platform neutralizing DNMT1 function and controlling DNA methylation. | Nat Commun | 2023 | 36609400 | PubTator, text mining | PubMed |
| Optimization and validation of a protein phosphatase inhibition assay for accessible microcystin detection. | Talanta | 2023 | 36608426 | PubTator, text mining | PubMed |
| A DNA biosensors-based microfluidic platform for attomolar real-time detection of unamplified SARS-CoV-2 virus. | Biosens Bioelectron X | 2023 | 36589921 | PubTator, text mining | PubMed |
| HIV-1 Transcription Inhibitor 1E7-03 Decreases Nucleophosmin Phosphorylation. | Mol Cell Proteomics | 2023 | 36563749 | PubTator, text mining | PubMed |
| Preservation of red blood cell antigenicity in a new storage solution in vitro. | Ann Med | 2023 | 36519679 | PubTator, text mining | PubMed |
Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high-dose chemotherapy independent of MIPI and complement established highrisk factors. | Haematologica | 2023 | 36519324 | PubTator, text mining | PubMed |
| Phosphorylation of PBX2, a novel downstream target of mTORC1, is determined by GSK3 and PP1. | J Biochem | 2023 | 36477205 | PubTator, text mining | PubMed |
| Regulation of PP1 interaction with I-2, neurabin, and F-actin. | Mol Cell Neurosci | 2023 | 36442541 | PubTator, text mining | PubMed |
| Proteome derangement in malignant epithelial cells and its stroma following exposure to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. | Arch Toxicol | 2023 | 36434399 | PubTator, text mining | PubMed |
| Human Papillomavirus E1 Protein Regulates Gene Expression in Cells Involved in Immune Response. | Appl Biochem Biotechnol | 2023 | 36418714 | PubTator, text mining | PubMed |
Adherence, Persistence, Readmissions, and Costs in Medicaid Members with Schizophrenia or Schizoaffective Disorder Initiating Paliperidone Palmitate Versus Switching Oral Antipsychotics: A Real-World Retrospective Investigation. | Adv Ther | 2023 | 36348142 | PubTator, text mining | PubMed |
| The clinical and molecular landscape of congenital myasthenic syndromes in Austria: a nationwide study. | J Neurol | 2023 | 36308527 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5464/papers?page=17